Rowland Charles A Jr bought VKTX
October 27, 2025 · Form 4 insider transaction
Rowland Charles A Jr bought 22,000 shares of Viking Therapeutics, Inc. at $5.80 per share, a transaction worth $127.6K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
22,000
Price
$5.80
Total value
$127.6K
InsiderRowland Charles A Jr
RoleDirector
SecurityCommon Stock, par value $0.00001 per share
Transaction codeA: Grant or award
Transaction dateOctober 27, 2025
Filing dateOctober 28, 2025
Shares owned after68,000
OwnershipDirect
10b5-1 planNo
AmendedNo